Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of reproductive age — affecting approximately 8 to 13 percent of women globally, with estimates in India running considerably higher. Despite its prevalence, PCOS remains widely misunderstood: under-diagnosed in some women, over-diagnosed in others, and too frequently managed with generic protocols that fail to address the individual complexity of the condition.

At Balaji Horizon Women’s Hospital, Dr. Priyadatt Patel approaches PCOS as a metabolic, endocrine, and reproductive condition simultaneously — not simply a period problem or a cosmetic concern. This guide is for women in Ahmedabad and across Gujarat who want to understand what PCOS actually is, how it is properly diagnosed, and what long-term management genuinely involves.

What Is PCOS? Understanding the Condition Accurately

PCOS is a syndrome — a cluster of features that tend to occur together — rather than a single disease with a single cause. The three main features used for diagnosis are:

Oligo- or anovulation: Irregular or absent ovulation, resulting in irregular menstrual cycles
Hyperandrogenism: Elevated androgens (male hormones), either measured biochemically or visible as acne, hirsutism, or hair thinning
Polycystic ovarian morphology: Multiple small follicles visible on ultrasound — though this finding alone is insufficient for a PCOS diagnosis

The Rotterdam criteria (2003), used internationally, requires two of these three features for diagnosis. Crucially, polycystic-appearing ovaries on ultrasound without clinical or hormonal evidence of PCOS does not constitute a diagnosis. Mislabelling a woman with PCOS based on imaging alone causes unnecessary anxiety and leads to inappropriate treatment.

Why PCOS Is More Than a Menstrual Problem

The consequences of PCOS extend well beyond irregular periods. Understanding its systemic effects is central to appropriate long-term management.

Metabolic Consequences

Between 50 to 70 percent of women with PCOS have insulin resistance — a state in which the body responds less effectively to insulin, leading to compensatory hyperinsulinemia. This drives androgen excess, worsens ovulatory function, and significantly increases long-term risk of type 2 diabetes and metabolic syndrome. Assessment of insulin sensitivity — through fasting glucose, HbA1c, or a formal oral glucose tolerance test — should be part of every PCOS evaluation.

Cardiovascular Risk

Women with PCOS have a higher prevalence of dyslipidemia (particularly elevated triglycerides and low HDL cholesterol), hypertension, and endothelial dysfunction. These translate into elevated cardiovascular risk over time, particularly when metabolic features remain unaddressed through the reproductive years and beyond.

Psychological Impact

Rates of anxiety, depression, and body image disturbance are significantly elevated in women with PCOS compared to the general population. These are not incidental — they are part of the clinical picture and should be assessed at diagnosis and during follow-up consultations.

Endometrial Risk

Chronic anovulation leads to prolonged, unopposed oestrogen stimulation of the endometrial lining. Without regular shedding, this increases the risk of endometrial hyperplasia and, over time, endometrial cancer. Achieving regular menstrual cycles — whether through lifestyle modification, oral contraceptives, or cyclical progestogens — is an important protective measure for every woman with PCOS who is not trying to conceive.

Diagnosis: What a Thorough Evaluation Should Include

A proper PCOS evaluation at Balaji Horizon Women’s Hospital includes the following:

Detailed menstrual history: Cycle length, frequency, and pattern since menarche
Clinical androgen assessment: Evaluation of skin, hair pattern, and weight distribution — including structured scoring for hirsutism where relevant
Hormone panel: LH, FSH, total and free testosterone, DHEAS, SHBG, prolactin, thyroid function
Metabolic panel: Fasting glucose, fasting insulin, HbA1c, lipid profile
Pelvic ultrasound: Ovarian volume, antral follicle count, and distribution — ideally transvaginal for accuracy
AMH (anti-Müllerian hormone): A useful adjunct marker of ovarian follicular activity, though not diagnostic in isolation

PCOS should never be diagnosed on ultrasound findings alone. Many adolescents and young women have polycystic-appearing ovaries as part of normal pubertal development — premature labelling can cause lasting harm.

PCOS Management: An Individualised, Long-Term Approach

The management of PCOS is not a single treatment. It is an individualised strategy built around the woman’s primary concern, her metabolic profile, her reproductive goals, and her capacity for sustainable behaviour change. The following represents the structured approach used at our clinic in Ahmedabad.

1. Lifestyle Modification — The Foundation of PCOS Treatment

For women with overweight or obesity and PCOS, even a 5 to 10 percent reduction in body weight can significantly improve ovulation frequency, menstrual regularity, androgen levels, and insulin sensitivity. This is not a matter of motivation — it requires structured guidance on:

Dietary composition: higher protein, lower refined carbohydrate, adequate fibre to reduce postprandial insulin spikes
Meal timing: avoiding prolonged fasting followed by large carbohydrate loads
Physical activity: a combination of aerobic exercise and resistance training, both of which improve insulin sensitivity independently of weight loss

For women with significant insulin resistance, lifestyle modification alone may be insufficient to achieve regular ovulation — but it remains the foundation on which all other interventions are layered.

2. Insulin-Sensitising Agents

Metformin is the most evidence-supported insulin sensitiser in PCOS. Its primary mechanism involves reducing hepatic glucose output and fasting insulin, which indirectly lowers androgen production and can improve ovulation frequency over time. When combined with structured lifestyle change, particularly in women with documented insulin resistance, it provides clinically meaningful benefit for metabolic control and menstrual regularity.

Myo-inositol, often combined with D-chiro-inositol, has accumulating evidence in PCOS — particularly for improving egg quality in women undergoing IVF stimulation. However, it is not yet a first-line guideline recommendation, and its use should be contextualised within an individually designed treatment plan.

3. Hormonal Management

Combined oral contraceptive pills (COCPs) remain first-line treatment for women with PCOS who are not seeking pregnancy. They regularise cycles (providing endometrial protection), suppress androgen excess, and improve acne and hirsutism over time. COCPs containing anti-androgenic progestogens — such as drospirenone or cyproterone acetate — are generally preferred for women with significant hyperandrogenism.

Cyclical progestogens are an alternative for women who cannot or prefer not to use combined contraceptives — providing endometrial protection without systemic hormonal suppression.

4. Fertility Management in PCOS

For women with PCOS actively trying to conceive, ovulation induction is the primary intervention. Current ESHRE/ASRM guidelines recommend letrozole (an aromatase inhibitor) as the preferred first-line agent, given its higher live birth rates and lower risk of multiple pregnancy compared to clomiphene citrate in PCOS. Gonadotropin injections are used when oral ovulation induction fails, but require close monitoring due to the elevated risk of ovarian hyperstimulation syndrome (OHSS) in PCOS.

IVF is reserved for cases where ovulation induction has failed, where additional fertility factors are present, or where age and ovarian reserve considerations make first-line approaches inappropriate. In women with PCOS undergoing IVF, careful stimulation protocol selection and proactive OHSS prevention strategies are non-negotiable components of treatment planning.

5. Long-Term Monitoring

PCOS is a lifelong condition. Its hormonal and metabolic features may evolve with age, pregnancy, and weight changes — but the underlying tendency persists. Women with PCOS should receive periodic structured reviews including:

Metabolic markers (glucose, insulin, lipids) every 1 to 3 years depending on baseline risk and current treatment
Blood pressure monitoring
Psychological screening for anxiety and depression
Menstrual cycle review to confirm ongoing endometrial protection in non-pregnant, non-contraceptive users

PCOS in Adolescents: A Note on Caution

Diagnosing PCOS in teenagers requires particular caution. Irregular cycles and polycystic-appearing ovaries are relatively common in the early years following menarche, as normal pubertal development continues for several years after the first period. A diagnosis of PCOS should generally be deferred until at least two years after menarche, and only confirmed when features clearly exceed what is expected for normal pubertal transition.

PCOS Treatment at Balaji Horizon Women’s Hospital, Ahmedabad

Dr. Priyadatt Patel evaluates PCOS as a systemic condition — addressing its hormonal, metabolic, and reproductive dimensions within a single, coherent management framework. Every woman presenting with suspected or confirmed PCOS receives a structured evaluation followed by a treatment plan built around her specific clinical profile and personal priorities.

If you have been told you have PCOS — or if you are experiencing irregular periods, difficulty conceiving, unexplained weight gain, acne, or hirsutism — a proper clinical evaluation is the right starting point. Self-diagnosis based on ultrasound findings alone, or treatment without thorough assessment, consistently leads to suboptimal outcomes.

To book a consultation at our PCOS treatment clinic in Ahmedabad, contact Balaji Horizon Women’s Hospital at +91 9909496027. We also offer comprehensive IVF and fertility treatment in Ahmedabad for women with PCOS-related infertility.